Categories Analysis, Consumer

Procter & Gamble (PG) raises sales outlook despite significant headwinds

Organic sales is expected to grow 4-5% in FY2023

Shares of The Procter & Gamble Company (NYSE: PG) were down on Thursday following the announcement of its earnings results for the second quarter of 2023. Revenue beat expectations while earnings matched estimates. The company also raised its sales outlook for the full year of 2023. The stock has gained 13% in the past three months.

Quarterly performance

Procter & Gamble generated net sales of $20.8 billion in the second quarter of 2023, which fell 1% year-over-year but came ahead of estimates of $20.7 billion. Organic sales grew 5%, driven by higher pricing and positive product mix. Core EPS fell 4% year-over-year to $1.59 but was in line with expectations.

Trends

On a reported basis, P&G recorded single-digit sales declines across its Beauty, Grooming, and Baby, Feminine & Family Care segments during the second quarter while sales inched up in the Health Care and Fabric & Home Care segments by 2% and 1% respectively.

On an organic basis, sales increased across all segments, driven by higher pricing, with the exception of Grooming, which remained flat. The highest growth came from Health Care and Fabric & Home Care which both saw sales increase 8%. Organic sales gains were offset by volume declines across all segments.

Within the Beauty segment, Hair Care sales rose in the mid-single digits helped by pricing but this was partly offset by volume declines due to market contraction. Within Health Care, Oral Care volumes were impacted by portfolio reduction in Russia and pandemic-related disruptions in Greater China. Organic sales in Personal Care increased in the high-teens due to pricing, favorable mix and volume growth driven by the cough, cold and flu season.

Outlook

P&G raised its sales outlook for fiscal year 2023 and now expects all-in sales to be down 1% to in-line versus the prior fiscal year. The previous expectation was for a decline of 3% to 1%. In addition, organic sales is now expected to grow 4-5% YoY versus the prior range of 3-5% growth.

The company maintained its full-year outlook for EPS growth in the range of in-line to up 4% versus last year. Due to significant cost headwinds from commodity and materials costs and foreign exchange impacts, EPS is likely to trend towards the lower end of the guidance range.

Click here to read more on consumer stocks

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Infographic: Key metrics from Estee Lauder’s (EL) Q3 2024 earnings results

The Estee Lauder Companies Inc. (NYSE: EL) reported its third quarter 2024 earnings results today. Net sales were $3.94 billion, up 5% from the prior-year quarter. Organic sales increased 6%.

YUM Earnings: Key quarterly highlights from Yum! Brands’ Q1 2024 financial results

Yum! Brands, Inc. (NYSE: YUM) reported first quarter 2024 earnings results today. Total revenues decreased 3% year-over-year to $1.59 billion. Same-store sales declined 3%. Net income increased 5% to $314

Pfizer (PFE) Q1 2024 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported first quarter 2024 earnings results today. Revenues decreased 20% year-over-year to $14.8 billion. Reported net income declined 44% to $3.1 billion, or $0.55 per share,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top